P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia

Published:2016-12-16 Issue: Volume:7 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Trino Stefania,De Luca Luciana,Laurenzana Ilaria,Caivano Antonella,Del Vecchio Luigi,Martinelli Giovanni,Musto Pellegrino

Funder

Ministero della Salute

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference83 articles.

1. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.;Agirre;Oncogene,2003

2. Clinical updates in adult acute lymphoblastic leukemia.;Al Ustwani;Crit. Rev. Oncol. Hematol,2016

3. Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in Leukemia.;Andreeff;Clin. Cancer Res,2016

4. The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia.;Benjamin;Ther. Adv. Hematol.,2016

5. Unravelling mechanisms of p53-mediated tumour suppression.;Bieging;Nat. Rev. Cancer,2014

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening;Analytical Biochemistry;2024-11

2. An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues;Cancer Letters;2024-08

3. An Mdm2 Degrader Shows Potent Cytotoxicity to Mdm2-Overexpressing Acute Lymphoblastic Leukemia Cells with Minimal Toxicity to Normal Cells/Tissues;2024

4. Tetrahydrobiopterin from cyanide‐degrading bacterium Bacillus pumilus strain SVD06 induces apoptosis in human lung adenocarcinoma cell (A549);Biotechnology and Applied Biochemistry;2023-09-20

5. One-pot three-component synthesis, in vitro anticancer activity and p53-MDM2 protein-protein interaction inhibition of novel spiro-oxindoline-based pyrazolo[3,4-b]pyridines;Egyptian Journal of Chemistry;2023-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3